ECP 2019 Final Programme

Wednesday, 11 Sept 115 ECP 2019 · Nice Poster Sessions a Wednesday PS-20 011 The use of Stochastic Optical Reconstruc- tion Microscopy (STORM) in formalin fixed paraffin embedded tissue Scarlet Brockmoeller, United Kingdom K. Kouvidi, H. Slaney, R. Hughes, A. Curd, M. Peckham, P. Quirke 013 Helicobacter pylori infection: a compara- tive prospective study of histochemical stains versus real-time diagnosis with EndoFaster® test Alejandra Caminoa-Lizarralde, Spain I. Carretero-Barrio, T. Rodajo-Fernandez, E. Romio, E. Sanchez-Rodriguez, E. Vazquez-Sequeiros, C. Perna Monroy 014 Clinicopathologic features of radiation-in- duced enteritis: a monocentric surgical study of 41 patients with outcome correlations Dominique Cazals-Hatem, France J. Didier, J. Cros, N. Guedj, Y. Panis, F. Joly 015 Prognostic perspectives of PD-L1 combined with tumour-infiltrating lymphocytes, Epstein-Barr virus infection, and microsatellite instability in gastric carcinomas Mee Soo Chang, Republic of Korea E. Choi, S. Byeon, S. Park 017 Immunogenic phenotype of EBV-negative mismatch repair proficient gastric cancer Bastian Dislich, Switzerland N. Blaser, B. Gloor, K. Mertz, R. Langer 018 Mis-match repair protein antibodies and their performance in the UK National External Quality Assessment Scheme for Immunocytochemistry and In-Situ Hybridisation (UK NEQAS ICC & ISH) Andrew Dodson, United Kingdom S. Parry 019 Is there an optimal definition for positive circumferential resection margin in oesophageal cancer? Charlotte Dufour, France B. Brac, H. Behal, M. Messier, E. Leteurtre, C. Mariette, G. Piessen, F. Renaud 020 Gastric signet ring cell carcinoma: a comparative analysis of clinicopathologic features Boubacar Efared, Morocco J. Nshizirungu, N. Hammas, H. El Fatemi, L. Chbani 022 Expression of FAP-1 in colorectal adenocarcinoma associated fibroblasts Caner Ercan, Switzerland M. Coto-Llerena, V. Kancherla, G. Nicolas, L. Terracciano, S. Piscuoglio, M. Fani 023 Development of a mismatch repair immunohistochemistry clinical trial assay and novel BRAF V600E antibody Hayley Finkelstein, USA V. Tennant, C. Mayhew, S. Soleimani, S. Tabuena-Frolli, J. Lee, T. Haase, F. Aidt, E. Oroudjev 024 Eosinophil counts in colon biopsies can predict treatment response to vedol- izumab in Inflammatory Bowel Disease Ruben Gabriëls, The Netherlands A. R. Bourgonje, G. Trentadue, K. N. Faber, G. Dijkstra, G. Kats-Ugurlu 026 The influence of the genetic and immuno- logic context in the development of colorectal adenoma Diogo Garcia, Irene Gullo, Portugal L. Spaans, S. Miranda, J. Reis, J. L. Costa, F. Carneiro, J. C. Machado 027 Assessment of colorectal resection specimens for the predictor features of presence of tumour deposits and lymph node characteristics: importance of mucinous tumour histology Rabia Burcin Girgin, Turkey G. Kir, T. Soylemez, S. Gundogdu, I. Tosun, A. Gapbarov, G. Bas, O. Alimoglu